Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
NCT01169194 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2400
Last updated 2026-01-16
Summary
The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will ask for information about your health. The investigators will also ask you to give us a blood sample so that they may discover the genes that cause IBD. The blood sample may be collected at Johns Hopkins or any local facility convenient to you.
Conditions
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - lead OTHER
Principal Investigators
-
Mark Lazarev, MD · Johns Hopkins University
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-06-30
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- United States
Study Locations
More Related Trials
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Collection of Specimens for Study of Inflammatory Bowel Disease
NCT00086554 ·Status: COMPLETED
-
IBD Registry in a Sub-Saharan African Population
NCT04178408 ·Status: RECRUITING
-
Inflammatory Bowel Disease Research Registry
NCT00574028 ·Status: COMPLETED
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181 ·Status: COMPLETED ·Phase: NA
-
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
NCT05663671 ·Status: UNKNOWN
-
Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease
NCT00808262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CorEvitas Inflammatory Bowel Disease (IBD) Registry
NCT03162549 ·Status: ENROLLING_BY_INVITATION
-
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Characterization of Phenotype and Genotype of Early Onset Enteropathies
NCT02614911 ·Status: RECRUITING
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease
NCT03698500 ·Status: UNKNOWN ·Phase: NA
-
GWA Study in Patients With Inflammatory Bowel Disease
NCT01140789 ·Status: RECRUITING
-
Mucosal Innate Immune Activation in Chronic Intestinal Disorders
NCT03529318 ·Status: WITHDRAWN
-
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
NCT01854242 ·Status: COMPLETED
-
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678 ·Status: COMPLETED
-
Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
NCT00833170 ·Status: COMPLETED
-
Prevalence of Lymphoma in IBD
NCT00577538 ·Status: COMPLETED
-
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease
NCT04088773 ·Status: ACTIVE_NOT_RECRUITING
-
Diet Study on Ulcerative Colitis
NCT04147598 ·Status: COMPLETED ·Phase: NA
-
Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
NCT01293656 ·Status: WITHDRAWN
-
G-CSF to Treat Crohn's Disease
NCT00025805 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers to Predict and Monitor Response to Infliximab
NCT04655729 ·Status: UNKNOWN